Status:

RECRUITING

Effects of Transcranial Direct Current Stimulation (tDCS) in the Management of Suicidal Ideation

Lead Sponsor:

Centre Hospitalier Henri Laborit

Conditions:

Depression and Suicide

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The main objective of this study is to demonstrate that 15 transcranial direct current stimulation (tDCS) sessions of 30 minutes at 2 mA intensity are effective to reduce suicidal ideation

Detailed Description

After being informed about the study and potential risks, all patients giving written informed consent will undergo a screening visit to determine eligibility for study entry. Patient who meet the eli...

Eligibility Criteria

Inclusion

  • Age over 18 years
  • Written informed consent
  • Diagnosis of recurrent or isolated depressive episode according to DSM IV criteria (A.P.A. 1994).
  • Stable antidepressant treatment for 3 weeks
  • MADRS score ≥ 20
  • SSI score \> 3
  • Subject affiliated to a health insurance system
  • Woman with effective contraception and agreeing to maintain it throughout the study period.

Exclusion

  • Depression with psychotic features Axis I (DSM IV) co-morbid diagnosis of schizophrenia, alcohol and/or other substance dependence (or abuse) (lifetime)
  • Patient who has already undergone an electroconvulsive therapy course for the current episode and does not respond to this treatment
  • Patient deprived of liberty
  • Patient with high suicide risk (item 10 MADRS \> 4) in the absence of hospitalization
  • Contraindication to tDCS: intracerebral metallic implant (with the exception of dental implants), cardiac pacemaker, active or non-implanted devices in the region of the head, acute eczema in the planned stimulation area
  • Pregnant, parturient or breastfeeding woman
  • Simultaneous participation in another interventional research

Key Trial Info

Start Date :

October 26 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2027

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06009523

Start Date

October 26 2023

End Date

December 1 2027

Last Update

June 5 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Centre Hospitalier Nord-Deux-Sèvres

Faye-l'Abbesse, France

2

Centre Hospitalier Henri Laborit

Poitiers, France